tiprankstipranks
Trending News
More News >
Zelira Therapeutics (AU:ZLD)
ASX:ZLD
Australian Market
Advertisement

Zelira Therapeutics (ZLD) Technical Analysis

Compare
5 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Zelira Therapeutics’s (ZLD) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Zelira Therapeutics is a Sell.
Zelira Therapeutics’s (ZLD) 20-Day exponential moving average is 0.41, while Zelira Therapeutics’s (ZLD) share price is AU$0.41, making it a Sell.
Zelira Therapeutics’s (ZLD) 50-Day exponential moving average is 0.42, while Zelira Therapeutics’s (ZLD) share price is AU$0.41, making it a Sell.

Zelira Therapeutics (ZLD) Pivot Points

Aug 12, 2025, 11:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.40
0.40
0.41
0.41
0.42
0.42
0.43
Fibonacci
0.40
0.41
0.41
0.41
0.42
0.42
0.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zelira Therapeutics (ZLD) Moving Averages

Aug 12, 2025, 11:43 PM
Period
Simple
Exponential
MA5
0.41Sell
0.41Sell
MA10
0.41Sell
0.41Sell
MA20
0.41Sell
0.41Sell
MA50
0.42Sell
0.42Sell
MA100
0.43Sell
0.45Sell
MA200
0.52Sell
0.53Sell
Zelira Therapeutics’s (ZLD) 10-Day exponential moving average is 0.41, while Zelira Therapeutics’s (ZLD) share price is AU$0.41, making it a Sell.
Zelira Therapeutics’s (ZLD) 100-Day exponential moving average is 0.45, while Zelira Therapeutics’s (ZLD) share price is AU$0.41, making it a Sell.
Zelira Therapeutics’s (ZLD) stock price is AU$0.41 and Zelira Therapeutics’s (ZLD) 50-day simple moving average is 0.42, creating a Sell signal.
Zelira Therapeutics’s (ZLD) stock price is AU$0.41 and Zelira Therapeutics’s (ZLD) 100-day simple moving average is 0.43, creating a Sell signal.
Zelira Therapeutics’s (ZLD) stock price is AU$0.41 and Zelira Therapeutics’s (ZLD) 200-day simple moving average is 0.52, creating a Sell signal.

Zelira Therapeutics (ZLD) Technical Indicators

Aug 12, 2025, 11:43 PM
Name
Value
Implied Action
RSI (14)
42.04
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
17.75
Buy
Williams %R
-100.00
Buy
CCI (14)
2.57
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
4.29
Sell
ROC
0.00
Sell
Zelira Therapeutics’s (ZLD) Relative Strength Index (RSI) is 42.04, creating a Neutral signal.
Zelira Therapeutics’s (ZLD) Trend Strength Indicator (ADX) is 17.75, creating a Buy signal.
Zelira Therapeutics’s (ZLD) Commodity Channel Index (CCI) is 2.57, creating a Neutral signal.

FAQ

Is ZLD a Buy, Hold, or Sell?
Based on ZLD’s technical indicators, ZLD is a Sell.
    What is ZLD’s RSI (14)?
    ZLD’s RSI (14) is 42.04, which suggests ZLD is a Neutral.
      What is ZLD’s MACD?
      ZLD’s MACD is >-0.01, which suggests ZLD is a Sell.
        What is ZLD’s 5-day moving average?
        ZLD’s 5-day moving average is 0.41, which suggests ZLD is a Sell.
          What is ZLD’s 20-day moving average?
          ZLD 20-day moving average is 0.41, which suggests ZLD is a Sell.
            What is ZLD’s 50-day moving average?
            ZLD’s 50-day moving average is 0.42, which suggests ZLD is a Sell.
              What is ZLD’s 200-day moving average?
              ZLD’s 200-day moving average is 0.52, which suggests ZLD is a Sell.
                What is ZLD’s Williams % R (14)?
                ZLD’s Williams % R (14) is -100.00, which suggests ZLD is a Buy.
                  What is ZLD’s CCI (14)?
                  ZLD’s CCI (14) is 2.57, which suggests ZLD is a Neutral.
                    What is the share price of Zelira Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis